Cargando…
A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression
BACKGROUND: Long non-coding RNAs (LncRNAs) have been increasingly confirmed to be abnormally expressed in human cancer and closely related to tumorigenesis. LncRNA ACTA2-AS1 is abnormally expressed in multiple tumors and participates in their development. However, whether ACTA2-AS1 plays a role in t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409411/ https://www.ncbi.nlm.nih.gov/pubmed/32774166 http://dx.doi.org/10.1186/s12935-020-01471-w |
_version_ | 1783568057372770304 |
---|---|
author | Luo, Lingli Wang, Min Li, Xianping Luo, Can Tan, Shan Yin, Sheng Liu, Lei Zhu, Xiaolin |
author_facet | Luo, Lingli Wang, Min Li, Xianping Luo, Can Tan, Shan Yin, Sheng Liu, Lei Zhu, Xiaolin |
author_sort | Luo, Lingli |
collection | PubMed |
description | BACKGROUND: Long non-coding RNAs (LncRNAs) have been increasingly confirmed to be abnormally expressed in human cancer and closely related to tumorigenesis. LncRNA ACTA2-AS1 is abnormally expressed in multiple tumors and participates in their development. However, whether ACTA2-AS1 plays a role in the development of cervical cancer (CC) and the exact mechanism of its role has not been elucidated. METHODS: Quantitative real-time PCR (qRT-PCR) was conducted to detect the expression level of messenger RNA of ACTA2-AS1, miR-143-3p and SMAD3 in tumor tissues and cells. Additionally, SMAD3 protein expression by western blots in cells. Small interference RNA against ACTA2‐AS1 or SMAD3 and miR‐143‐3p mimic/inhibitor was designed and transfected into CC cell lines to investigate their correlations and potential impacts on cell function. Cell Counting Kit-8 (CCK-8) assay, colony formation, cell cycle assay, transwell assay and flow cytometry analysis were performed to detect the specific effects on cell line proliferation, metastasis and apoptosis. RESULTS: ACTA2-AS1 was significantly increased in CC tissues and cells and miR‐143‐3p was down-regulated. Clinically, the higher expression of ACTA2-AS1 was significantly correlated with higher FIGO stage. Loss-of-function assay revealed that silencing of ACTA2-AS1 inhibited cell proliferation, colony formation, migration and promoted apoptosis in CC. Additionally, Pearson correlation analysis showed that the expression of ACTA2-AS1 and miR-143-3p were negatively correlated. Dual-luciferase reporter assay and further mechanistic experiments confirmed that ACTA2-AS1 could sponge and regulate the expression of miR-143-3p. Furthermore, SMAD3 was the target gene of miR-143-3p and ACTA2-AS1 could upregulate SMAD3 through acting as a competitive endogenous RNA (ceRNA) of miR-143-3p. Finally, rescue assay demonstrated that the ACTA2-AS1/miR-143-3p/SMAD3 axis played an important role in the proliferation, migration and apoptosis of CC cells. CONCLUSIONS: In summary, our study revealed that ACTA2-AS1 upregulates SMAD3 by competitively binding miR-143-3p, thereby accelerating CC progression. The ACTA2-AS1/miR-143-3p/SMAD3 axis can play a crucial role in cervical carcinogenesis, providing new clues for the early diagnosis and treatment of CC. |
format | Online Article Text |
id | pubmed-7409411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74094112020-08-07 A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression Luo, Lingli Wang, Min Li, Xianping Luo, Can Tan, Shan Yin, Sheng Liu, Lei Zhu, Xiaolin Cancer Cell Int Primary Research BACKGROUND: Long non-coding RNAs (LncRNAs) have been increasingly confirmed to be abnormally expressed in human cancer and closely related to tumorigenesis. LncRNA ACTA2-AS1 is abnormally expressed in multiple tumors and participates in their development. However, whether ACTA2-AS1 plays a role in the development of cervical cancer (CC) and the exact mechanism of its role has not been elucidated. METHODS: Quantitative real-time PCR (qRT-PCR) was conducted to detect the expression level of messenger RNA of ACTA2-AS1, miR-143-3p and SMAD3 in tumor tissues and cells. Additionally, SMAD3 protein expression by western blots in cells. Small interference RNA against ACTA2‐AS1 or SMAD3 and miR‐143‐3p mimic/inhibitor was designed and transfected into CC cell lines to investigate their correlations and potential impacts on cell function. Cell Counting Kit-8 (CCK-8) assay, colony formation, cell cycle assay, transwell assay and flow cytometry analysis were performed to detect the specific effects on cell line proliferation, metastasis and apoptosis. RESULTS: ACTA2-AS1 was significantly increased in CC tissues and cells and miR‐143‐3p was down-regulated. Clinically, the higher expression of ACTA2-AS1 was significantly correlated with higher FIGO stage. Loss-of-function assay revealed that silencing of ACTA2-AS1 inhibited cell proliferation, colony formation, migration and promoted apoptosis in CC. Additionally, Pearson correlation analysis showed that the expression of ACTA2-AS1 and miR-143-3p were negatively correlated. Dual-luciferase reporter assay and further mechanistic experiments confirmed that ACTA2-AS1 could sponge and regulate the expression of miR-143-3p. Furthermore, SMAD3 was the target gene of miR-143-3p and ACTA2-AS1 could upregulate SMAD3 through acting as a competitive endogenous RNA (ceRNA) of miR-143-3p. Finally, rescue assay demonstrated that the ACTA2-AS1/miR-143-3p/SMAD3 axis played an important role in the proliferation, migration and apoptosis of CC cells. CONCLUSIONS: In summary, our study revealed that ACTA2-AS1 upregulates SMAD3 by competitively binding miR-143-3p, thereby accelerating CC progression. The ACTA2-AS1/miR-143-3p/SMAD3 axis can play a crucial role in cervical carcinogenesis, providing new clues for the early diagnosis and treatment of CC. BioMed Central 2020-08-05 /pmc/articles/PMC7409411/ /pubmed/32774166 http://dx.doi.org/10.1186/s12935-020-01471-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Luo, Lingli Wang, Min Li, Xianping Luo, Can Tan, Shan Yin, Sheng Liu, Lei Zhu, Xiaolin A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title | A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title_full | A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title_fullStr | A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title_full_unstemmed | A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title_short | A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression |
title_sort | novel mechanism by which acta2-as1 promotes cervical cancer progression: acting as a cerna of mir-143-3p to regulate smad3 expression |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409411/ https://www.ncbi.nlm.nih.gov/pubmed/32774166 http://dx.doi.org/10.1186/s12935-020-01471-w |
work_keys_str_mv | AT luolingli anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT wangmin anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT lixianping anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT luocan anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT tanshan anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT yinsheng anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT liulei anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT zhuxiaolin anovelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT luolingli novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT wangmin novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT lixianping novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT luocan novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT tanshan novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT yinsheng novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT liulei novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression AT zhuxiaolin novelmechanismbywhichacta2as1promotescervicalcancerprogressionactingasacernaofmir1433ptoregulatesmad3expression |